Primary immunodeficiency can increase your risk of many other health issues, so managing it is key to staying healthy. See how well you’re doing, and get simple steps for improving your immunity. It's ...
Living with primary immunodeficiency (PI) means getting sick more often than others, taking a long time to recover from an illness, and experiencing recurring infections. The uncertainty and ...
On April 28, 2026 the Jeffrey Modell Foundation (JMF) will host Luigi D. Notarangelo, M.D., the Chief of the Immune Deficiency Genetics Section at the National Institute of Allergy and Infectious ...
Please provide your email address to receive an email when new articles are posted on . The FDA approval makes Hyqvia available for children aged 2 to 16 years with primary immunodeficiency. The ...
Alyglo is manufactured using cation exchange chromatography, which reduces coagulation factor XIa to undetectable levels. Alyglo ™ (immune globulin intravenous, human-stwk) 10% liquid is now available ...
Please provide your email address to receive an email when new articles are posted on . Children born to mothers, not fathers, with primary antibody immunodeficiencies had greater risks for certain ...
Last month, Takeda revealed it was building a new manufacturing facility in Japan which would increase the company’s capacity for plasma production nearly fivefold in that country. Three weeks later, ...
FRISCO, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex ...
The acute SBI rate was 0.03 during the 12-month study period, which met the predefined success rate of less than 1 acute SBI per patient per year. The Food and Drug Administration (FDA) has approved ...
Immune system disorders in children can involve an underactive, overactive, or misdirected immune response. Main groups include immunodeficiencies, autoimmune diseases, atopic diseases, and ...
Mortality risk higher among children with primary immunodeficiency diseases infected with SARS-CoV-2
Children with certain immunodeficiency diseases carry mutations in genes that regulate the body's immune system against viral infections and they have a higher mortality rate due to COVID-19. This is ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved leniolisib phosphate (Joenja) for treating adults and adolescents aged 12 years and older weighing 45 kg or more with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results